X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. PANACEA BIOTECH FDC LTD./
PANACEA BIOTECH
 
P/E (TTM) x 24.2 155.1 15.6% View Chart
P/BV x 5.0 3.4 146.2% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 FDC LTD.   PANACEA BIOTECH
EQUITY SHARE DATA
    FDC LTD.
Mar-14
PANACEA BIOTECH
Mar-14
FDC LTD./
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs144149 96.5%   
Low Rs7982 96.0%   
Sales per share (Unadj.) Rs47.684.1 56.5%  
Earnings per share (Unadj.) Rs7.6-18.3 -41.6%  
Cash flow per share (Unadj.) Rs9.0-6.7 -134.5%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.583.7 56.8%  
Shares outstanding (eoy) m177.8361.25 290.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.31.4 170.4%   
Avg P/E ratio x14.6-6.3 -231.7%  
P/CF ratio (eoy) x12.3-17.2 -71.6%  
Price / Book Value ratio x2.31.4 169.6%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,7847,074 279.7%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m1,2211,449 84.2%   
Avg. sales/employee Rs ThNM1,874.1-  
Avg. wages/employee Rs ThNM527.0-  
Avg. net profit/employee Rs ThNM-407.7-  
INCOME DATA
Net Sales Rs m8,4595,154 164.1%  
Other income Rs m394100 394.3%   
Total revenues Rs m8,8525,254 168.5%   
Gross profit Rs m2,070-766 -270.2%  
Depreciation Rs m249711 35.0%   
Interest Rs m311,503 2.1%   
Profit before tax Rs m2,184-2,881 -75.8%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m-225-6 3,945.6%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m60617 3,604.5%   
Profit after tax Rs m1,353-1,121 -120.7%  
Gross profit margin %24.5-14.9 -164.6%  
Effective tax rate %27.7-0.6 -4,754.8%   
Net profit margin %16.0-21.8 -73.5%  
BALANCE SHEET DATA
Current assets Rs m4,3553,810 114.3%   
Current liabilities Rs m1,7928,365 21.4%   
Net working cap to sales %30.3-88.4 -34.3%  
Current ratio x2.40.5 533.6%  
Inventory Days Days44156 28.6%  
Debtors Days Days2567 36.7%  
Net fixed assets Rs m3,02514,480 20.9%   
Share capital Rs m17961 291.4%   
"Free" reserves Rs m8,243903 912.7%   
Net worth Rs m8,4535,127 164.9%   
Long term debt Rs m115,832 0.2%   
Total assets Rs m10,55719,433 54.3%  
Interest coverage x71.4-0.9 -7,792.2%   
Debt to equity ratio x01.1 0.1%  
Sales to assets ratio x0.80.3 302.1%   
Return on assets %13.12.0 667.5%  
Return on equity %16.0-21.9 -73.2%  
Return on capital %23.53.6 646.5%  
Exports to sales %13.324.5 54.3%   
Imports to sales %3.310.2 32.8%   
Exports (fob) Rs m1,1261,264 89.1%   
Imports (cif) Rs m283525 53.9%   
Fx inflow Rs m1,1461,539 74.5%   
Fx outflow Rs m355942 37.7%   
Net fx Rs m791597 132.4%   
CASH FLOW
From Operations Rs m1,485599 247.8%  
From Investments Rs m-620-438 141.5%  
From Financial Activity Rs m-753-303 248.7%  
Net Cashflow Rs m113-141 -79.8%  

Share Holding

Indian Promoters % 68.9 74.5 92.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 0.6 783.3%  
FIIs % 7.5 1.3 576.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 23.6 80.5%  
Shareholders   23,730 10,259 231.3%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   CADILA HEALTHCARE  J.B.CHEMICALS  ORCHID PHARMA LTD  BIOCON LTD  FULFORD INDIA  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jan 22, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS